生物标志物 生物标志物
Eduardo R Zimmer1,2,3, Wyllians Vendramini Borelli4, Pamela C L Ferreira5
1Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
血液生物标志物在巴西对阿尔茨海默病 (AD) 诊断有希望. 虽然p-tau217准确地将AD与认知障碍区分开来,但将AD与血管痴呆症区分开来需要进一步的研究.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
- 全球健康差异的差异
背景情况:
- 阿尔茨海默病 (AD) 生物标志物研究主要来自全球北方人口.
- 基于血液的生物标志物提供了一个潜在的解决方案,以减少AD研究的全球差异.
- 在一些人群中,较低的教育程度可能会影响生物标志物的表现.
研究的目的:
- 为了评估血生物标志物在巴西队列中用于AD诊断的现实世界表现.
- 评估Aβ40,Aβ42,p-tau217,NfL和GFAP在区分AD与认知无障碍 (CU) 和血管痴呆症 (VaD) 个体中的准确性.
- 讨论血液生物标志物发现对巴西痴呆症倡议的影响.
主要方法:
- 在巴西记忆诊所队列 (n=59) 中分析了血生物标志物 (Aβ40,Aβ42,p-tau217,NfL,GFAP).
- 生物标志物在区分AD与CU和VaD方面的性能比较.
- 用于测量诊断准确性的曲线下的利用面积 (AUC).
主要成果:
- 血p-tau217在区分AD和CU个体方面表现出高准确性 (AUC为0.96).
- 所有测试的血生物标志物在区分AD和VaD方面的表现都低于预期 (AUC0.520.79).
- 调查结果基于对一个多元化的巴西队列的初步分析.
结论:
- 血p-tau217显示出在不同人群中作为AD的诊断生物标志物的潜力.
- 需要进一步的研究来优化血液生物标志物的性能,以区分AD和VaD,特别是在教育程度较低的人群中.
- 血液生物标志物对于为国家痴呆症战略提供信息和减少健康差异至关重要.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


